Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AH02
|
| gptkbp:bioavailability |
80%
|
| gptkbp:brand |
gptkb:Tamiflu
|
| gptkbp:CASNumber |
gptkb:179474-86-7
|
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:hasMolecularFormula |
C16H28N2O4
|
| gptkbp:hasSMILES |
CCOC(=O)C1=C(C(CC(C)CC)O1)NC(=O)C
|
| gptkbp:hasUNII |
R7T0KZ6CMO
|
| https://www.w3.org/2000/01/rdf-schema#label |
179474-86-7
|
| gptkbp:IUPACName |
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
neuraminidase inhibitor
|
| gptkbp:meltingPoint |
205-206 °C
|
| gptkbp:molecularWeight |
312.4 g/mol
|
| gptkbp:name |
gptkb:Oseltamivir
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL123
65028 DB00198 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting headache |
| gptkbp:usedFor |
treatment of influenza A
treatment of influenza B |
| gptkbp:bfsParent |
gptkb:prucalopride
|
| gptkbp:bfsLayer |
7
|